Lynx1 Capital Management’s VYNE Therapeutics VYNE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$973K Buy
2024
Q4
Sell
2024
Q3
$30.4K Hold
2024
Q2
$31.9K Buy